Sponsor Pipeline

Sitala Bio LTD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-08 NCT07606352
Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy		 Recruitment opened
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07606352 Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy IgAN Recruiting
NCT07606365 A Study in Adults With Geographic Atrophy Geographic Atrophy Not Yet Recruiting
Get alerts when Sitala Bio LTD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free